LifeStance Health Group Announces Board Changes and Executive Compensation Updates
Ticker: LFST · Form: 8-K · Filed: Aug 22, 2025 · CIK: 1845257
| Field | Detail |
|---|---|
| Company | Lifestance Health Group, Inc. (LFST) |
| Form Type | 8-K |
| Filed Date | Aug 22, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, director-election
Related Tickers: LSTA
TL;DR
LSTA board shakeup: new directors in, one out, exec comp details filed.
AI Summary
LifeStance Health Group, Inc. announced on August 19, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure of Director David M. Shane and the election of new directors, including Dr. Michelle R. Riba and Dr. Robert L. T. Smith. The filing also details compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.
Risk Assessment
Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership effectiveness.
Key Players & Entities
- LifeStance Health Group, Inc. (company) — Registrant
- David M. Shane (person) — Departing Director
- Dr. Michelle R. Riba (person) — Newly Elected Director
- Dr. Robert L. T. Smith (person) — Newly Elected Director
- August 19, 2025 (date) — Date of earliest event reported
FAQ
Who has departed from the Board of Directors?
David M. Shane has departed from the Board of Directors.
Who are the newly elected directors?
Dr. Michelle R. Riba and Dr. Robert L. T. Smith have been elected as new directors.
What is the date of the earliest event reported in this 8-K?
The earliest event reported is dated August 19, 2025.
What items are covered in this 8-K filing?
This filing covers the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the principal executive office address for LifeStance Health Group, Inc.?
The principal executive office is located at 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona, 85251.
Filing Stats: 489 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-08-22 16:39:24
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Mar
Filing Documents
- d863673d8k.htm (8-K) — 23KB
- 0001193125-25-186460.txt ( ) — 133KB
- lfst-20250819.xsd (EX-101.SCH) — 3KB
- lfst-20250819_lab.xml (EX-101.LAB) — 18KB
- lfst-20250819_pre.xml (EX-101.PRE) — 11KB
- d863673d8k_htm.xml (XML) — 4KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2025 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 4800 N. Scottsdale Road Suite 2500 Scottsdale , Arizona 85251 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Code: 425 279-8500 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 19, 2025, William Miller notified the LifeStance Health Group, Inc. (the "Company") board of directors (the "Board") of his resignation from the Board and all of its committees, effective immediately. The resignation is not a result of any disagreement between Mr. Miller and the Company. In connection with Mr. Miller's resignation, on August 20, 2025, the Board appointed Sarah Personette as a director of the Company. In connection with her appointment, pursuant to the Company's 2021 Equity Incentive Plan, Ms. Personette received an initial award of 74,766 restricted stock units that will vest according to the terms of a time-and performance-based restricted stock unit agreement, subject to Ms. Personette's continued service on the Board. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFESTANCE HEALTH GROUP, INC. Date: August 22, 2025 By: /s/ Ryan Pardo Name: Ryan Pardo Title: Chief Legal Officer and Secretary